Abstract
Introduction

Transplantation of mesenchymal stem cells (MSCs) derived from adult bone marrow has been proposed as a potential therapeutic approach for post-infarction left ventricular (LV) dysfunction. MSCs can protect cardiomyocytes by expressing genes encoding factors that are matrix-mediating, anti-apoptotic and angio-/arteriogenic, as interleukin (IL)-6, leukaemia inhibitory factor (LIF) and vascular endothelial growth factor (VEGF) family
, prompt angiogenesis in injured area by secreting angiogenetic and vasculogenetic products, particularly VEGF, hepatocyte growth factors, adrenomedullin, placental growth factor and IL-6 [1] . MSCs were found to incorporate into vascular vessel walls of growing neovasculature during cardiac tissue regeneration [2] and to transmigrate over the endothelial barrier of capillaries, disrupting tight junctions between endothelial cells and developing tight cell-cell contacts with the endothelial cells on its way [3] . Li et al. [4] transplanted Bcl-2 modified MSCs into the infarcted heart in a rat model and found that some of the MSCs appeared to display endothelial cell-like phenotype. They [5] . Clinical studies revealed a reduction of perfusion defect along with improved overall LV function after intracoronary autologous MSCs administration [6] .
also confirmed that a very few number of MSCs colocalized with cardiac Troponin T (cTnT) by the 3D reconstruction of the tissue acquired by a confocal microscopy, suggesting the fusion of the transplanted MSCs with host cells or the differentiation of the transplanted cells into cardiomyocytes. Intramyocardial transplantation of MSCs led to initial enhancement of coronary blood flow and subsequent improvement of cardiac performance 8 weeks after transient cardiac ischemia in pigs
However, the beneficial effect regarding functional recovery after ischemia in patients was much less effective than predicted by preclinical studies. Notably, most preclinical studies were performed on healthy young animals, whereas most patients enrolled in clinical trials were older patients with multiple comorbidities [7] .
Diminished stem cell functions with age have been extensively documented in previous studies [8] [9] [10] [11] [12] [13] [14] . Aging leads to a reduction of telomere length of bone marrow derived cells especially in patients with cardiovascular diseases [15] [16] [17] , reduces cell survival to ischemic injury, incurs less stem cell release of VEGF and basic fibroblast growth factor (bFGF) in response to ischemia [7] . Fortunately the aging-related decline in cardiac and vascular regenerative capacity of stem cells could be addressed by pre-activation of donor cells with genetic modification before implantation. Indeed, genetic manipulation of rat MSCs with prosurvival kinase Akt [18] , anti-apoptotic Bcl-2 [4] and genetic modification of EPCs with human telomerase reverse transcriptase [19] , and VEGF [20] have induced [21, 22] . Actually, genetic engineering of human stem cells with VEGF by biodegradable polymeric nanoparticles showed enhanced angiogenesis in a mouse ischemic hindlimb model [23] .
In this study, we used the polyethylenimine (PEI; 25 kD), a widely used non-viral gene carrier with high delivery efficiency [22, [24] [25] [26] [27] 
Materials and methods
Chemicals and reagents
PEI/DNA complexes preparation and characterization
The PEI/DNA complexes were prepared as we described previously [22, 28, 29] 
Results
PEI/DNA complexes characterization
DNA immobilization by PEI was studied by electrophoresis. As shown in Figure 1A , with the increase of N/P ratio, the DNA retardation increased. At the absence of PEI (N/P ratio ϭ 0), the naked DNA showed a broad and bright band under the UV illuminator. However, with the gradually increased N/P ratio, the DNA band became narrower and weaker. Finally, the DNA band disappeared at N/P ratio 1 indicating that the DNA was completely retarded. The size and surface charge of complexes are important factors which affect the transfection efficiency [30] . Figure 1B 
hMSCs characterization
The immunophenotyping of cell surface antigens was examined by flow cytometry. As shown in Figure 2A, (Fig. 2B) .
MTT cytotoxicity assay
The cytotoxicity induced by PEI/DNA complexes was studied by MTT assay (Fig. 3) Figure 4B . The green fluorescent protein (GFP) expression of transfected cells at the optimal conditions are shown in Figure 4C- Figure 5A revealed (Fig. 5C ).
In vitro transfection optimization
To optimize the transfection conditions, three hMSC samples were used for gene delivery assay with various N/P ratio and DNA dosage. The representative results from FACS analysis (Fig. 4A) showed that both N/P ratio and DNA dosage could influence the gene delivery efficiency. At N/P ratio 1, although the efficiency increased with the increase of DNA dosage, it was still very low even at high DNA dosage (5.98% at 8.0 g DNA/cm 2 ). When the N/P ratio increased to 2, the efficiency was enhanced and showed a maximum peak (24.24%) at 6.0 g DNA/cm 2 . After that, the efficiency showed a decreasing trend with the increase of N/P ratio. The FACS analysis histograms at N/P ratio 2 with various DNA dosages are shown in
Effect of cell resource on transfection efficiency
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Fig. 1 Characterization of PEI/DNA complexes. Plasmid DNA was increasingly retarded by PEI with the increase of N/P ratio, until the complete retardation at N/P ratio 1 (A). PEI/DNA complex size was reduced, whereas potential was increased with the increase of N/P ratio from 0.5 to 12 (B).
Effect of S phase on transfection efficiency
Previous works have revealed that the cells in S phase achieved significant higher transfection efficiency than the cells in G1
phase [31, 32] . The effect of S phase on the transfection efficiency was investigated in this study (Fig. 6A) Figure 6B . In addition, phenotypic characterization was performed with cells of these two subpopulations and there was no significant difference observed on the surface markers: CD29, CD44, CD45, CD73 and CD105 (Fig. 6C ).
10). A representative histogram of cell cycle analysis via PI staining and FACS detection is shown in
Human VEGF165 Transfection
To investigate whether PEI could mediate the delivery of therapeutic gene into hMSC, the cells were transfected with human VEGF165 gene (Fig. 7) [32] . Both studies showed that the transfection efficiency was strongly dependent on the cell cycle stage at the time of transfection, and the higher transfection efficiency appeared during S or G2/M phase. We tried to verify whether the cell cycle dependence finding based on the cell line studies from Professor Wagner's group [31, 32] 
